David P. Luci - President and CEO, Director at Acurx Pharmaceuticals, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David P. Luci since 12 Aug 2025

Reported holdings for David P. Luci in Acurx Pharmaceuticals, Inc.

Form 4 holding President and CEO, Director

Acurx Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,097,458
Estimated value
$1,113,920
Report date
06 Jan 2025
Price
$1.02
Ownership
Direct
Form 4 holding President and CEO, Director

Acurx Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
35,000
Estimated value
$35,525
Report date
06 Jan 2025
Price
$1.02
Ownership
By child
Form 4 holding President and CEO, Director

Acurx Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
15,083
Estimated value
$15,309
Report date
06 Jan 2025
Price
$1.02
Ownership
By spouse
Form 4 holding President and CEO, Director

Acurx Pharmaceuticals, Inc.

Security class
Stock Option
Shares / value
250,000
Estimated value
Report date
23 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and CEO, Director

Acurx Pharmaceuticals, Inc.

Security class
Warrants for Common Stock
Shares / value
49,261
Estimated value
Report date
06 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for David P. Luci in Acurx Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .